Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 665

1.

In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.

Schoster A, Kokotovic B, Permin A, Pedersen PD, Dal Bello F, Guardabassi L.

Anaerobe. 2013 Apr;20:36-41. doi: 10.1016/j.anaerobe.2013.02.006. Epub 2013 Mar 5.

PMID:
23471038
2.

In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study.

Fredua-Agyeman M, Stapleton P, Basit AW, Beezer AE, Gaisford S.

Int J Pharm. 2017 Jan 30;517(1-2):96-103. doi: 10.1016/j.ijpharm.2016.12.005. Epub 2016 Dec 5.

PMID:
27923699
3.

In vitro and in vivo antagonistic activity of new probiotic culture against Clostridium difficile and Clostridium perfringens.

Golić N, Veljović K, Popović N, Djokić J, Strahinić I, Mrvaljević I, Terzić-Vidojević A.

BMC Microbiol. 2017 May 6;17(1):108. doi: 10.1186/s12866-017-1015-5.

4.

In Vitro Antimicrobial Activity and Probiotic Potential of Bifidobacterium and Lactobacillus against Species of Clostridium.

Monteiro CRAV, do Carmo MS, Melo BO, Alves MS, Dos Santos CI, Monteiro SG, Bomfim MRQ, Fernandes ES, Monteiro-Neto V.

Nutrients. 2019 Feb 21;11(2). pii: E448. doi: 10.3390/nu11020448.

5.

Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile.

Kondepudi KK, Ambalam P, Nilsson I, Wadström T, Ljungh A.

Anaerobe. 2012 Oct;18(5):489-97. doi: 10.1016/j.anaerobe.2012.08.005. Epub 2012 Aug 24.

PMID:
22940065
6.

Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.

Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M.

J Appl Microbiol. 2006 Jun;100(6):1324-32.

7.

Competitive inhibition of three novel bacteria isolated from faeces of breast milk-fed infants against selected enteropathogens.

Muñoz-Quezada S, Bermudez-Brito M, Chenoll E, Genovés S, Gomez-Llorente C, Plaza-Diaz J, Matencio E, Bernal MJ, Romero F, Ramón D, Gil A.

Br J Nutr. 2013 Jan;109 Suppl 2:S63-9. doi: 10.1017/S0007114512005600.

PMID:
23360882
8.

Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains?

Tejero-Sariñena S, Barlow J, Costabile A, Gibson GR, Rowland I.

Anaerobe. 2013 Dec;24:60-5. doi: 10.1016/j.anaerobe.2013.09.011. Epub 2013 Sep 30.

PMID:
24091275
9.

Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants.

Trejo FM, Minnaard J, Perez PF, De Antoni GL.

Anaerobe. 2006 Aug;12(4):186-93. Epub 2006 Jun 8.

PMID:
16759886
10.

In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids.

Tejero-Sariñena S, Barlow J, Costabile A, Gibson GR, Rowland I.

Anaerobe. 2012 Oct;18(5):530-8. doi: 10.1016/j.anaerobe.2012.08.004. Epub 2012 Aug 24.

PMID:
22959627
11.

Isolation, identification and characterisation of three novel probiotic strains (Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036) from the faeces of exclusively breast-fed infants.

Muñoz-Quezada S, Chenoll E, Vieites JM, Genovés S, Maldonado J, Bermúdez-Brito M, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F, Suárez A, Ramón D, Gil A.

Br J Nutr. 2013 Jan;109 Suppl 2:S51-62. doi: 10.1017/S0007114512005211.

PMID:
23360881
12.

Development of antimicrobial synbiotics using potentially-probiotic faecal isolates of Lactobacillus fermentum and Bifidobacterium longum.

Likotrafiti E, Tuohy KM, Gibson GR, Rastall RA.

Anaerobe. 2013 Apr;20:5-13. doi: 10.1016/j.anaerobe.2013.01.002. Epub 2013 Jan 24.

PMID:
23354005
13.

In vitro evaluation of single- and multi-strain probiotics: Inter-species inhibition between probiotic strains, and inhibition of pathogens.

Chapman CM, Gibson GR, Rowland I.

Anaerobe. 2012 Aug;18(4):405-13. doi: 10.1016/j.anaerobe.2012.05.004. Epub 2012 Jun 4.

PMID:
22677262
14.

Prebiotic preferences of human lactobacilli strains in co-culture with bifidobacteria and antimicrobial activity against Clostridium difficile.

Ambalam P, Kondepudi KK, Balusupati P, Nilsson I, Wadström T, Ljungh Å.

J Appl Microbiol. 2015 Dec;119(6):1672-82. doi: 10.1111/jam.12953. Epub 2015 Nov 9.

15.

In vitro evaluation of Lactobacillus gasseri strains of infant origin on adhesion and aggregation of specific pathogens.

Ferreira CL, Grześkowiak L, Collado MC, Salminen S.

J Food Prot. 2011 Sep;74(9):1482-7. doi: 10.4315/0362-028X.JFP-11-074.

PMID:
21902917
16.

Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study.

Keller MK, Hasslöf P, Stecksén-Blicks C, Twetman S.

Acta Odontol Scand. 2011 Sep;69(5):263-8. doi: 10.3109/00016357.2011.554863. Epub 2011 Feb 9.

PMID:
21306197
17.

Probiotic properties of Lactobacillus and Bifidobacterium strains isolated from porcine gastrointestinal tract.

Kim PI, Jung MY, Chang YH, Kim S, Kim SJ, Park YH.

Appl Microbiol Biotechnol. 2007 Apr;74(5):1103-11. Epub 2006 Nov 29.

PMID:
17136367
18.

A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.

Rätsep M, Kõljalg S, Sepp E, Smidt I, Truusalu K, Songisepp E, Stsepetova J, Naaber P, Mikelsaar RH, Mikelsaar M.

Anaerobe. 2017 Oct;47:94-103. doi: 10.1016/j.anaerobe.2017.03.019. Epub 2017 Apr 29.

PMID:
28465256
19.

Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.

Mogna L, Del Piano M, Deidda F, Nicola S, Soattini L, Debiaggi R, Sforza F, Strozzi G, Mogna G.

J Clin Gastroenterol. 2012 Oct;46 Suppl:S29-32. doi: 10.1097/MCG.0b013e31826852b7.

PMID:
22955353
20.

Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.

Zhou JS, Pillidge CJ, Gopal PK, Gill HS.

Int J Food Microbiol. 2005 Feb 1;98(2):211-7.

PMID:
15681048

Supplemental Content

Support Center